Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017)

Adma Biologics (ADMA) reported Change in Acquisitions & Divestments of $245000.0 for Q2 2017, up 106.67% on a YoY basis from $118546.5 in Q2 2016, and down 95.24% quarter-over-quarter from $5.1 million in Q1 2017.

Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017) Analysis & Trends

Adma Biologics has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $245000.0 in Q2 2017.

  • For the quarter ending Q2 2017, Change in Acquisitions & Divestments rose 106.67% year-over-year to $245000.0; the trailing twelve-month figure through Mar 2018 stood at $245000.0 (down 98.65% YoY), and the FY2017 full-year result was $5.4 million, down 67.64% from the prior year.
  • Change in Acquisitions & Divestments for Q2 2017 stood at $245000.0, down from $5.1 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $16.7 million in Q4 2016, with the low at -$3.7 million in Q2 2016.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Adma Biologics 1.98 Bn 1.89 Bn 88.82 Mn

Historic Data

Download Data
DateValue
Jun 30, 2017 245,000.00
Jun 30, 2017 245,000.00
Mar 31, 2017 5.15 Mn
Mar 31, 2017 5.15 Mn
Dec 31, 2016 16.66 Mn
Dec 31, 2016 16.66 Mn
Jun 30, 2016 -3.67 Mn
Jun 30, 2016 -3.67 Mn
Mar 31, 2016 3.67 Mn
Mar 31, 2016 3.67 Mn